Herbalife (NYSE:HLF – Free Report) had its price target boosted by Mizuho from $8.00 to $9.00 in a report issued on Friday, Benzinga reports. They currently have a neutral rating on the stock.
Other research analysts also recently issued reports about the stock. B. Riley lowered their price objective on shares of Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, October 31st. DA Davidson dropped their price objective on Herbalife from $13.00 to $7.50 and set a “neutral” rating for the company in a research report on Thursday, October 31st. Citigroup decreased their target price on Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Finally, StockNews.com cut shares of Herbalife from a “buy” rating to a “hold” rating in a report on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Herbalife presently has a consensus rating of “Hold” and a consensus price target of $10.42.
Read Our Latest Stock Analysis on HLF
Herbalife Price Performance
Herbalife (NYSE:HLF – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. Sell-side analysts expect that Herbalife will post 1.34 earnings per share for the current fiscal year.
Insider Activity
In other Herbalife news, Director Juan Miguel Mendoza bought 10,000 shares of Herbalife stock in a transaction on Monday, September 9th. The shares were purchased at an average cost of $7.11 per share, with a total value of $71,100.00. Following the acquisition, the director now directly owns 120,000 shares of the company’s stock, valued at $853,200. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.94% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Herbalife
Several institutional investors and hedge funds have recently made changes to their positions in HLF. GAMMA Investing LLC lifted its stake in shares of Herbalife by 465.3% in the second quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock worth $37,000 after acquiring an additional 2,908 shares during the period. nVerses Capital LLC boosted its stake in shares of Herbalife by 240.0% in the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock valued at $53,000 after purchasing an additional 3,600 shares during the last quarter. Public Employees Retirement System of Ohio increased its position in shares of Herbalife by 22.9% during the first quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company’s stock worth $56,000 after buying an additional 1,035 shares during the period. Carolina Wealth Advisors LLC bought a new position in Herbalife during the third quarter worth $78,000. Finally, Van ECK Associates Corp lifted its holdings in Herbalife by 10.3% in the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock valued at $90,000 after buying an additional 808 shares during the period.
Herbalife Company Profile
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Featured Articles
- Five stocks we like better than Herbalife
- Overbought Stocks Explained: Should You Trade Them?
- Intel: Is Now the Time to Be Brave?
- How to Evaluate a Stock Before Buying
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Which Wall Street Analysts are the Most Accurate?
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.